Cormorant Asset Management, LP Scholar Rock Holding Corp Transaction History

Cormorant Asset Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$7.2 - $13.2 $856,440 - $1.57 Million	-118,950 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$8.95 - $15.72 $277,897 - $488,106	-31,050 Reduced 20.7%	118,950 $1.07 Million
Q2 2019 Aug 14, 2019	SELL	$14.61 - $22.45 $422,097 - $648,602	-28,891 Reduced 16.15%	150,000 $2.38 Million
Q1 2019 May 15, 2019	SELL	$14.24 - $22.28 $444,102 - $694,846	-31,187 Reduced 14.85%	178,891 $3.36 Million
Q2 2018 Aug 14, 2018	BUY	$15.0 - $25.6 $3.15 Million - $5.38 Million	210,078 New	210,078 $3.28 Million

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $1.95B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.